Low-Flow Anesthesia Techniques: Safety and Efficiency in Small Animals

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Low-flow anesthesia, defined as fresh gas flow (FGF) below 1 L/min in a rebreathing circuit, significantly reduces inhalant consumption, cost, and greenhouse gas emissions by approximately 52% based on observed reductions in FGF from 1.27 to 0.61 L/min.
• Implementing low-flow anesthesia necessitates a functional circle rebreathing system with adequate CO2 absorbent, continuous and accurate agent and oxygen monitoring (e.g., infrared analyzers, oxygen analyzers), and disciplined adjustment of vaporizer settings based on end-tidal concentrations.
• The wash-in phase is critical for establishing target anesthetic depth, requiring an initial high-flow period (10-15 minutes at 3-4 L/min) before reducing FGF, as inspired agent concentration lags behind vaporizer settings at low flows due to circuit equilibration dynamics.
• Maintaining adequate oxygenation requires ensuring inspired oxygen concentration remains above 30% throughout maintenance, which is achievable at FGFs of 14-20 mL/kg/min when the carrier gas contains 50% oxygen, but vigilance is paramount due to potential for oxygen depletion.
• Carbon dioxide elimination relies solely on the CO2 absorbent; its freshness and proper packing are essential, as exhaustion or channeling can lead to hypercapnia that may not be immediately apparent without end-tidal CO2 monitoring.
• Contraindications include circuit leaks, inadequate monitoring capabilities, and very small patients (<5 kg), as circuit integrity is paramount and leaks become proportionally more significant at lower FGFs, potentially causing unrecognized hypoxemia or inadequate agent delivery.

Low-flow anesthesia, defined as fresh gas flow (FGF) below 1 L/min in a rebreathing circuit, offers measurable reductions in inhalant consumption, cost, and greenhouse gas emissions. For dogs and cats, the technique requires a functional circle system, accurate agent and oxygen monitoring, and disciplined adjustment of vaporizer settings during the wash-in and maintenance phases. This article provides the practicing veterinarian with the physiological rationale, circuit requirements, monitoring adaptations, and economic considerations needed to implement low-flow anesthesia safely in small animal patients.

The clinical question addressed here is direct: how low can FGF be set without compromising oxygen delivery, carbon dioxide elimination, or anesthetic depth control? The answer depends on patient size, circuit design, agent solubility, and the quality of gas monitoring available. Evidence from veterinary teaching hospitals demonstrates that structured low-flow protocols reduce mean FGF by approximately 52%, from 1.27 to 0.61 L/min, with a proportional reduction in inhalant-related emissions, while anesthesia staff report strong support for the protocol after targeted education Implementation of a low-flow intervention at a veterinary teaching hospital: an environmental initiative. Comparable findings in equine practice show that training programs alone reduce isoflurane and oxygen usage by 9.6% and 17.9%, respectively, across multiple hospitals Multi-center clinical audit of oxygen and inhalant anesthetic usage in equine anesthesia: The potential benefits of training and low-flow techniques.

This article is written for veterinarians who already manage inhalant anesthesia and seek a structured approach to reducing FGF. It does not cover exotic species, field anesthesia, or non-rebreathing circuits.

At a Glance

Physiology of Rebreathing and Gas Kinetics

The circle rebreathing system recirculates exhaled gases after carbon dioxide absorption, allowing the anesthetist to deliver oxygen and volatile agent at flows far below the patient's minute ventilation. At FGF of 0.5 to 1 L/min, the circuit acts as a reservoir whose gas composition approaches equilibrium with the patient's uptake. This equilibrium is governed by the agent's blood-gas partition coefficient: isoflurane and sevoflurane, with coefficients near 1.4 and 0.65 respectively, reach circuit steady state more slowly than desflurane but remain manageable at low flow. The inspired agent concentration becomes a function of vaporizer output, FGF, circuit volume, and ongoing patient uptake, instead of a direct reflection of the vaporizer dial.

Oxygen delivery at low flow depends on the balance between FGF oxygen content and patient consumption. A 20 kg dog consuming approximately 4 to 6 mL/kg/min of oxygen will extract a substantial fraction of the oxygen delivered at 14 mL/kg/min FGF. The remaining exhaled gas, after CO2 absorption, retains oxygen at a concentration that, when mixed with fresh gas, must keep FiO2 above 30%. Clinical studies in dogs confirm that inspired oxygen concentrations remain above this threshold at FGF of 14 and 20 mL/kg/min when carrier gas contains 50% oxygen Low flow anesthesia with isoflurane in the dog.

Carbon dioxide elimination is handled entirely by the absorbent, not by FGF. Soda lime or barium hydroxide lime must be fresh and adequately packed, because channeling or exhaustion produces hypercapnia that low-flow monitoring may not immediately reveal. End-tidal CO2 monitoring remains the sentinel check.

Agent Uptake and Circuit Dynamics

The wash-in phase establishes the circuit agent concentration. At high FGF, the circuit fills within minutes. At low FGF, the same process takes considerably longer, and the inspired concentration may lag behind the vaporizer setting by 20 to 30 minutes. Standard practice therefore begins with a high-flow period of 10 to 15 minutes at 3 to 4 L/min, after which FGF is reduced to the target low-flow rate. This approach was validated in human desflurane anesthesia, where an initial 10 to 15 minute high-flow phase at 4.4 L/min allowed safe reduction to 0.5 or 1.0 L/min with inspired concentrations maintained between 1 and 1.5 MAC Low-flow anesthesia with desflurane.

During maintenance, the vaporizer setting must be adjusted as uptake declines. The anesthetist should titrate against end-tidal agent concentration, not the vaporizer dial. Sevoflurane, being less soluble than isoflurane, reaches steady state faster and permits more rapid adjustment, but both agents are suitable for low-flow techniques in dogs. Recovery times after low-flow isoflurane anesthesia are shorter than after high-flow anesthesia, likely because lower circuit volumes of agent are present to delay elimination Low flow anesthesia with isoflurane in the dog.

Monitoring Adjustments at Low Flow

Gas analysis becomes the central monitoring modality at low FGF. Side-stream analyzers sample gas from the circuit and return it to the patient port, at low flow, this sampling can constitute a meaningful fraction of FGF, so the analyzer's return port must be connected properly. Mainstream analyzers avoid this issue but add dead space.

A specific failure mode involves short-wavelength infrared analyzers, which are sensitive to methane. Methane accumulates in rebreathing circuits at low flow, particularly in herbivores, and can cause isoflurane readings to drift upward over time. In horses, this measurement error increases with duration of low-flow anesthesia and is influenced by pre-anesthetic fasting, with fed animals producing more methane and greater error Isoflurane measurement error using short wavelength infrared techniques in horses: influence of fresh gas flow and pre-anesthetic food deprivation. Dogs produce less methane than horses, but the principle applies: long-wavelength or methane-insensitive analyzers are preferred for low-flow work, and any unexpected rise in agent reading should prompt suspicion of analyzer error instead of an immediate increase in vaporizer output.

Oxygen monitoring is mandatory. A fuel-cell or paramagnetic oxygen analyzer placed on the inspiratory limb confirms that FiO2 remains above 30%. Pulse oximetry provides a secondary check but responds slowly to circuit oxygen depletion.

Contraindications and Patient Selection

Low-flow anesthesia is appropriate for most healthy and moderately compromised dogs and cats weighing more than approximately 5 kg. Patients with high oxygen consumption, such as those with sepsis, severe anemia, or high fever, may require higher FGF to maintain FiO2. Morbidly obese patients and those with significant respiratory disease may also benefit from higher flows to compensate for ventilation-perfusion mismatch.

Circuit integrity is non-negotiable. A leak of 200 mL/min at a FGF of 500 mL/min represents a 40% loss of fresh gas and will produce unrecognized hypoxemia or inadequate agent delivery. Pressure testing the circuit, checking the vaporizer seal, and confirming one-way valve function before every low-flow case are mandatory steps. The AAHA anesthesia and monitoring guidelines for dogs and cats emphasize continuous monitoring of ventilation, oxygenation, and anesthetic depth, all of which become more demanding at low FGF AAHA Anesthesia and Monitoring Guidelines for Dogs and Cats.

Cost and Environmental Impact

The economic argument for low-flow anesthesia rests on proportional reductions in volatile agent consumption. A 52% reduction in FGF produces a 52% reduction in inhalant use and associated greenhouse gas emissions, as demonstrated in a veterinary teaching hospital intervention Implementation of a low-flow intervention at a veterinary teaching hospital: an environmental initiative. Isoflurane and sevoflurane are potent greenhouse gases, and their atmospheric release is directly proportional to the volume vaporized. Oxygen consumption also falls, reducing medical gas costs. The primary investment is staff training and the purchase of reliable agent and oxygen monitoring, both of which are standard equipment in most small animal anesthesia stations.

Circuit Requirements for Low-Flow Delivery

Low-flow anesthesia demands a rebreathing circuit with certain minimum specifications. A circle system with a functional carbon dioxide absorbent, unidirectional valves, and an adjustable pressure-limiting valve is mandatory. The circuit must be leak-free at the flows used, because even small leaks become proportionally more significant as fresh gas flow (FGF) decreases. Before each case, perform a pressure leak test to 20 to 30 cm H2O and verify that the circuit holds pressure for at least 30 seconds.

The vaporizer must be agent-specific and calibrated for the flow range employed. Most modern out-of-circuit vaporizers perform adequately at flows of 0.5 L/min or higher, but accuracy degrades at very low flows in some models. Desflurane requires a heated, electrically powered vaporizer, which adds a specific equipment consideration when this agent is selected for low-flow delivery Baum and colleagues' clinical investigation of low-flow desflurane.

Oxygen analysis is non-negotiable. At FGF below 1 L/min, the delivered oxygen concentration can drift unpredictably, particularly when nitrous oxide is used as a carrier gas. An inline oxygen analyzer with an alarm should be positioned on the inspiratory limb. The analyzer must be calibrated before each case and checked against room air and 100% oxygen.

Carbon dioxide absorbent quality directly affects safety at low flow. Soda lime and other absorbents consume water and heat as they neutralize carbon dioxide, and exhausted absorbent causes progressive hypercapnia that may be masked by normal capnography readings if the sample line draws from the wrong location. Replace absorbent when the indicator color changes, but verify with capnography instead of relying on color alone. Some newer absorbents contain no strong alkali and do not degrade sevoflurane into compound A, a consideration when sevoflurane is used at minimal flows.

Flow Rate Selection and the Decision Table

Flow rate selection depends on patient size, circuit volume, agent choice, and monitoring capability. Weight-based formulas are useful starting points, but circuit volume and the patient's metabolic rate matter more than body weight alone. A 5 kg dog with a 3 L circuit and a 40 kg dog with a 3 L circuit face different wash-in dynamics and different oxygen consumption relative to circuit volume.

The following table provides a framework for selecting maintenance FGF in dogs and cats. These values assume a rebreathing circuit with a functional absorber, continuous agent and oxygen monitoring, and controlled or assisted ventilation.

The wash-in phase at higher flow serves a specific purpose: it denitrogenates the circuit and rapidly establishes the target inspired agent concentration. Cutting this phase short prolongs the time to surgical depth and can mislead the anesthetist into increasing vaporizer settings prematurely. In dogs, FGF of 14 to 20 mL/kg/min has been evaluated as a low-flow maintenance regime with isoflurane, maintaining inspired oxygen above 30% and acceptable oxygenation and ventilation parameters Kramer and colleagues' comparison of low-flow isoflurane regimes in dogs. Sevoflurane at the same flow rates produces comparable safety profiles with shorter recovery times Kramer and colleagues' comparison of isoflurane and sevoflurane at low flow in dogs.

Cats present a specific challenge. Their small tidal volumes and high oxygen consumption relative to body mass mean that FGF below 0.5 L/min can allow oxygen concentration to fall if the vaporizer setting is high and nitrous oxide is used. For cats under 4 kg, a maintenance FGF of 0.5 to 0.8 L/min is a reasonable floor unless the circuit volume is very small and oxygen monitoring is continuous.

Vaporizer Management at Low Flow

Vaporizer settings at low flow do not equal delivered agent concentration. At FGF below 1 L/min, the inspired agent concentration approaches the vaporizer setting only after the circuit and the patient's functional residual capacity equilibrate. During the wash-in phase, set the vaporizer 20% to 40% higher than the target inspired concentration, then reduce the setting once the target end-tidal concentration is reached.

The relationship between vaporizer setting and delivered concentration changes as the patient's uptake stabilizes. Early in maintenance, uptake is high and the vaporizer must be set well above the target. After 30 to 60 minutes, uptake declines and the vaporizer setting may need to be reduced to avoid overdosage. This is the opposite of the pattern seen at high flow, where the vaporizer setting closely tracks the delivered concentration throughout.

When changing vaporizer settings at low flow, allow at least 5 to 10 minutes for the new concentration to equilibrate before reassessing. Frequent small adjustments are preferable to large swings. Document every vaporizer change and the corresponding end-tidal agent concentration so that trends are visible.

Monitoring Parameters Specific to Low Flow

Standard monitoring applies, but several parameters take on heightened importance at low flow.

Inspired oxygen concentration must be monitored continuously. At FGF below 1 L/min, oxygen consumption can reduce the inspired fraction if the vaporizer delivers a high agent concentration or if nitrous oxide is used. The AAHA anesthesia and monitoring guidelines for dogs and cats recommend continuous monitoring of oxygenation, ventilation, and cardiovascular function, with specific attention to the parameters that change when FGF is reduced AAHA anesthesia and monitoring guidelines.

Capnography at low flow requires attention to sampling site and sample flow rate. Side-stream analyzers withdraw gas from the circuit, and at very low FGF this sampling can create a negative pressure that pulls room air into the circuit through small leaks. Use a sampling rate of 50 to 100 mL/min and verify that the circuit remains leak-free. The capnogram waveform should be inspected for rebreathing, which appears as an elevated baseline or a failure of the waveform to return to zero.

Agent concentration monitoring becomes essential at low flow. The inspired and end-tidal agent concentrations diverge more at low flow than at high flow, and the difference between them reflects ongoing uptake. A widening gap between inspired and end-tidal agent suggests increasing uptake or a circuit problem. A narrowing gap suggests equilibration or impending overdose.

Methane interference is a documented source of error with short wavelength infrared agent analyzers. In horses, this error increases over time at low flow and is influenced by fasting status Dujardin and colleagues' evaluation of isoflurane measurement error with short wavelength infrared analysis. The same principle applies to dogs and cats, though the magnitude is smaller because of lower methane production. If the agent reading seems inconsistent with the clinical picture, cross-check with a second analyzer or switch to a long wavelength device.

Temperature monitoring is mandatory. Low flow reduces the heat and moisture loss that occurs at high flow, which is generally beneficial, but it also means that the patient's core temperature more directly reflects the circuit temperature. Hypothermia slows agent elimination and prolongs recovery.

Documentation and Protocol Structure

A standardized low-flow protocol improves compliance and reduces variability. The intervention at one veterinary teaching hospital reduced mean FGF from 1.27 to 0.61 L/min through staff education, visual aids, and a written protocol, with a corresponding 52% reduction in greenhouse gas emissions Elzahaby and colleagues' report on low-flow implementation at a veterinary teaching hospital. The same approach translates to private practice.

Document the following at least every 5 minutes during maintenance: FGF, vaporizer setting, inspired and end-tidal agent concentration, inspired oxygen fraction, end-tidal carbon dioxide, pulse rate, respiratory rate, blood pressure, and temperature. Record the time of each flow reduction and the rationale. Note any circuit leaks, absorbent changes, or analyzer recalibrations.

A written protocol should specify the wash-in flow and duration, the target maintenance flow for each weight category, the minimum acceptable inspired oxygen fraction, and the actions required if the inspired oxygen falls below that threshold. The protocol should also state which monitoring parameters must be present before flow is reduced, and which findings mandate a return to higher flow. These include unexplained hypoxemia, rising end-tidal carbon dioxide despite unchanged ventilation, suspected circuit leak, or analyzer malfunction.

The choice of agent affects the protocol. Sevoflurane's lower solubility allows faster adjustment of depth at low flow, but its higher cost per milliliter means that the savings from low flow are proportionally larger. Isoflurane is more forgiving of vaporizer inaccuracy at low flow because of its higher solubility. Desflurane requires specialized vaporizer equipment and has been studied in human low-flow protocols, but its use in small animal practice remains limited by equipment availability and cost Baum and colleagues' low-flow desflurane investigation.

Recognized Complications and Early Detection

Low-flow delivery compresses the margin for error that high-flow systems provide. The most clinically significant failure modes are oxygen depletion, carbon dioxide accumulation, and volatile agent overdosage or underdosage.

Oxygen depletion occurs when fresh gas flow falls below metabolic consumption. In dogs and cats, this risk is minimal when oxygen flow exceeds 30 to 50 mL/kg/min, but it becomes relevant in circuits with leaks, in patients with high oxygen consumption such as those with sepsis or hyperthermia, or when nitrous oxide is used as a carrier gas. Continuous inspired oxygen monitoring with an alarm set above 30% is the primary safeguard. The inspired oxygen concentration should be checked at flow reduction, at 15 minutes, and at least every 30 minutes thereafter.

Carbon dioxide accumulation arises from exhausted soda lime or from channeling within the absorbent canister. End-tidal carbon dioxide monitoring will show a rising baseline or an increasing inspired carbon dioxide value. The discriminating check is to measure the inspired carbon dioxide concentration directly, any value above 5 mmHg indicates absorbent exhaustion or channeling. Soda lime should be replaced when the inspired carbon dioxide exceeds this threshold, also when the indicator color changes, because color change can be unreliable under low-flow conditions.

Volatile agent underdosage is the most common error in the first 20 minutes after flow reduction. The circuit volume dilutes the vaporizer output, and the inspired agent concentration falls before the vaporizer setting is increased. The converse problem, overdosage, occurs when the vaporizer setting is not reduced after the initial wash-in period, particularly with sevoflurane, which is less soluble than isoflurane and equilibrates more quickly. Continuous agent monitoring with end-tidal values referenced to the patient's individual minimum alveolar concentration requirement is the only reliable method for detecting both errors. The study by Kramer and colleagues comparing isoflurane and sevoflurane at low flow in dogs confirmed that both agents maintain acceptable inspired oxygen and end-tidal carbon dioxide values when monitored continuously, but the authors emphasized that agent monitoring is mandatory at these flow rates.

Common Errors and Corrective Actions

Less experienced clinicians tend to make predictable mistakes. The first is reducing flow immediately after induction without allowing a wash-in period. The circuit and the patient's functional residual capacity must be equilibrated first, typically with a high flow of 100 to 200 mL/kg/min for 10 to 15 minutes, before flow reduction. The second error is failing to increase the vaporizer setting after flow reduction, which produces a gradual decline in inspired agent concentration that may not be noticed until the patient moves or shows a rising heart rate and blood pressure.

A third error is using a circle system that does not meet low-flow requirements. Unidirectional valves that stick, leaks at the patient connector or around the endotracheal tube cuff, and exhausted absorbent all become clinically significant at low flow. A pressure check of the circuit before connection to the patient, and a leak test of the endotracheal tube cuff after intubation, should be routine.

A fourth error is misinterpreting agent analyzer readings. Short wavelength infrared analyzers are sensitive to methane, which accumulates in the circuit at low flow and produces falsely elevated agent readings. Dujardin and colleagues demonstrated this effect in horses, where the measurement error increased over time at low flow and was influenced by the duration of pre-anesthetic food deprivation. The same principle applies in small animals, although the magnitude is smaller. If the agent analyzer reading does not match the clinical depth of anesthesia, a long wavelength analyzer or a different monitoring modality should be used for confirmation.

Troubleshooting Table

Limitations of the Evidence

The evidence base for low-flow anesthesia in small animals is narrower than in human anesthesia. The two canine studies by Kramer and colleagues provide data on isoflurane and sevoflurane at flow rates of 14 and 20 mL/kg/min, but both used a 50% nitrous oxide carrier gas, which is no longer common in many practices. The applicability of these results to oxygen-only carrier gas protocols is uncertain. The teaching hospital intervention reported by Elzahaby and colleagues demonstrated a 52% reduction in fresh gas flow and corresponding emissions after staff education and protocol standardization, but it did not report patient outcome data beyond the anesthetic records reviewed.

Expert opinion still differs on the minimum safe flow rate for small animals. Some clinicians advocate minimal-flow techniques at 10 to 15 mL/kg/min, while others prefer to remain above 20 mL/kg/min to preserve a larger safety margin. There is no published veterinary study that directly compares patient morbidity between these flow ranges. The AAHA anesthesia and monitoring guidelines for dogs and cats recommend continuous monitoring of oxygenation, ventilation, and agent concentration but do not specify a minimum flow rate, reflecting the absence of a definitive evidence base.

Referral and Escalation

Most complications of low-flow anesthesia are managed within the practice by adjusting flow, replacing absorbent, or correcting leaks. Referral to a specialist anesthetist is warranted when the practice lacks continuous agent monitoring or capnography, when a patient requires prolonged anesthesia with significant comorbidity, or when repeated episodes of hypotension or hypoxemia occur despite appropriate adjustments. Laboratory involvement is indicated when metabolic derangements are suspected, such as hypercapnia with respiratory acidosis that does not correct with ventilation adjustment, or when carbon monoxide exposure from degraded volatile agents is suspected. Regulatory reporting is not typically required for complications of low-flow anesthesia, but practices should follow their local professional standards for adverse event documentation and reporting where these exist.

Frequently Asked Questions

What fresh gas flow can I use if my anesthetic machine lacks a rebreathing circuit?

Low-flow techniques require a circle rebreathing system with carbon dioxide absorbent and unidirectional valves. If your machine has only a non-rebreathing circuit, such as a Bain or Lack system, you cannot safely reduce fresh gas flow below minute ventilation. In that setting, the minimum flow is dictated by the circuit design, typically 200 to 300 mL/kg/min in dogs and cats. Consider upgrading the machine or referring cases that would benefit from low-flow delivery. The AAHA anesthesia and monitoring guidelines describe circuit selection criteria and the monitoring expectations that apply regardless of circuit type.

How do I calculate the cost savings of low-flow anesthesia for my practice?

Track volatile agent consumption directly from vaporizer fill weights or from purchase records divided by anesthetic minutes. A standardized protocol with staff education reduced mean fresh gas flow by 52% in one teaching hospital, with a proportional reduction in inhalant use and emissions. To estimate local savings, record your current average flow rate, the agent used, and the number of anesthetic hours per month. Multiply the reduction in mL of liquid agent by your unit cost. Oxygen consumption falls as well, so include medical gas invoices in the calculation. The implementation study from a veterinary teaching hospital provides a practical framework for measuring pre- and post-intervention usage.

What monitoring adjustments are needed when I switch from high-flow to low-flow in a cat?

Cats tolerate low-flow delivery when cardiovascular status is stable, but the margin for error narrows. Inspired oxygen concentration must be checked directly, since oxygen consumption is proportionally larger relative to circuit volume in small patients. End-tidal carbon dioxide and agent concentrations require sidestream or mainstream sampling calibrated for the agent in use. Body temperature falls more slowly in a closed circuit, which can mask hypothermia, so monitor core temperature continuously. The AAHA monitoring guidelines specify minimum monitoring standards that apply to all feline anesthetics. If the cat is hypovolemic, anemic, or has significant cardiorespiratory disease, revert to higher flows.

How should I document low-flow anesthesia in the medical record?

Record the initial high-flow period, the time of flow reduction, the target flow rate, and the actual flow rate at each 5-minute interval. Document inspired and end-tidal oxygen, carbon dioxide, and agent concentrations, plus vaporizer settings. Note the absorbent color change and the time of any absorbent change. The AAHA anesthesia guidelines recommend continuous recording of physiologic parameters and anesthetic depth. A standardized low-flow protocol improves documentation consistency and reduces variability between anesthetists, as demonstrated in the teaching hospital intervention study. Include the calculated fresh gas flow per kilogram to allow comparison across cases.

Can I use low-flow anesthesia for short procedures under 30 minutes?

Low-flow technique is inefficient for very short procedures because the initial high-flow period occupies most of the anesthetic time. The benefit accrues during maintenance, so procedures expected to last less than 30 minutes rarely justify the wash-in phase. For procedures of 75 minutes or longer, low-flow delivery with isoflurane or sevoflurane maintained oxygen saturation above 97% and end-tidal carbon dioxide within normal range in dogs. Use high-flow for brief interventions and reserve low-flow for procedures where maintenance exceeds 45 to 60 minutes. This threshold is a practical guide, not a fixed rule, and should be adjusted for patient stability and monitoring capability.

How do I explain the environmental rationale for low-flow anesthesia to a client or hospital administrator?

Frame the discussion around measurable outcomes instead of general claims. Inhalational agents are potent greenhouse gases, and reducing fresh gas flow directly reduces emissions per anesthetic hour. The teaching hospital intervention reported a 52% reduction in emissions after implementing a standardized low-flow protocol, with strong staff support. For administrators, emphasize that lower agent and oxygen consumption reduces recurring supply costs without compromising patient safety. For clients, explain that the same anesthetic depth is achieved with less waste gas, which also reduces operating room pollution. The AVMA practice resources offer guidance on communicating practice sustainability initiatives to stakeholders.

Related Clinical & Scientific Guides

• Anesthetic Machine Leak Testing and Pressure Checks: A Step-by-Step Protocol
• Anesthetic Depth Assessment: Reflexes, Eye Position, and Ventilation
• Anesthesia for Patients with Obesity: Challenges and Solutions

References and Further Reading

• Implementation of a low-flow intervention at a veterinary teaching hospital: an environmental initiative.. 2026.
• [[Low-flow anesthesia with desflurane].](https://pubmed.ncbi.nlm.nih.gov/9229982/). 1997.
• Isoflurane measurement error using short wavelength infrared techniques in horses: influence of fresh gas flow and pre-anesthetic food deprivation.. 2005.
• [[Low flow anesthesia with isoflurane and sevoflurane in the dog].](https://pubmed.ncbi.nlm.nih.gov/18277780/). 2008.
• Multi-center clinical audit of oxygen and inhalant anesthetic usage in equine anesthesia: The potential benefits of training and low-flow techniques.. 2026.
• [[Low flow anesthesia with isoflurane in the dog].](https://pubmed.ncbi.nlm.nih.gov/15803765/). 2005.
• AAHA Anesthesia and Monitoring Guidelines for Dogs and Cats. AAHA.
• WSAVA Global Pain Council Guidelines. WSAVA.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.

Related Articles

• Anesthesia Machine Safety Features and Backup Systems
• Bovine Anesthesia and Analgesia: Field Techniques and Considerations
• Nerve Stimulator and Ultrasound Guidance for Regional Anesthesia in Small Animals
• Anesthesia for Patients with Skin Tumors: Excision and Reconstruction
• Anesthesia for Patients with Cancer: Paraneoplastic Syndromes

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.